8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)
Published . Updated .
8-K - RECURSION PHARMACEUTICALS filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- RXRX Recursion Pharmaceuticals+18.2% 14d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RXRX | +6.44% | +11.43% | base | after close | after close | after close | after close |
| XLV | -2.95% | -0.31% | base | after close | after close | after close | after close |
| XBI | +1.84% | +3.78% | base | after close | after close | after close | after close |
| LLY | -9.22% | -2.71% | base | after close | after close | after close | after close |
| JNJ | -0.68% | +1.70% | base | after close | after close | after close | after close |
| PFE | -3.00% | -2.47% | base | after close | after close | after close | after close |
| MRK | -4.45% | -1.43% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0001601830-26-000144 Size: 10 MB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory…
Source: sec-edgar
How far Recursion Pharmaceuticals (RXRX) has moved since 2 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | +1.70% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -0.68% | final price |
| Eli Lilly (LLY) | three days earlier | -2.71% | final price |
| Eli Lilly (LLY) | five days earlier | -9.22% | final price |
| Merck (MRK) | three days earlier | -1.43% | final price |
| Merck (MRK) | five days earlier | -4.45% | final price |
| Pfizer (PFE) | three days earlier | -2.47% | final price |
| Pfizer (PFE) | five days earlier | -3.00% | final price |
| Recursion Pharmaceuticals (RXRX) | three days earlier | +11.43% | final price |
| Recursion Pharmaceuticals (RXRX) | five days earlier | +6.44% | final price |
| Spdr Series Trust (XBI) | three days earlier | +3.78% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.84% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.31% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)”
Companies tied to this story
- RXRX Recursion Pharmaceuticals
In “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Recursion Pharmaceuticals (RXRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RXRX
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer).” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
In “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
For “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer).” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
Pfizer (PFE) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer).” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
In “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” reaches Recursion Pharmaceuticals (RXRX)
“8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” (2 Nov 2026) reaches Recursion Pharmaceuticals (RXRX) through this story.
The link for Recursion Pharmaceuticals (RXRX) is this: SEC 8-K filing -> direct issuer disclosure -> RXRX
A second company, Select Sector Spdr Tr (XLV), is listed for a different reason: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
The price range for Recursion Pharmaceuticals (RXRX), and the dates in the story
RXRX traded between 3.44 and 4.51 across 12 sessions. The latest close on file is 4.03.
How solid “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” looks
46 out of 100
“8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.